The CPEB3 Protein Is a Functional Prion that Interacts with the Actin Cytoskeleton  by Stephan, Joseph S. et al.
ArticleThe CPEB3 Protein Is a Functional Prion that
Interacts with the Actin CytoskeletonGraphical AbstractHighlightsd CPEB3 is a functional prion with a tripartite prion domain
architecture
d CPEB3 interacts with the actin cytoskeleton in yeast and at
mouse synapses
d Actin filaments are essential for CPEB3 prionization and actin
mRNA is a CPEB3 target
d Actin and CPEB3 constitute a positive feedback loop
important for CPEB3 functionStephan et al., 2015, Cell Reports 11, 1772–1785
June 23, 2015 ª2015 The Authors
http://dx.doi.org/10.1016/j.celrep.2015.04.060Authors
Joseph S. Stephan, Luana Fioriti,
Nayan Lamba, ..., Kevin Karl,
Irina L. Derkatch, Eric R. Kandel
Correspondence
irina.derkatch@gmail.com (I.L.D.),
erk5@columbia.edu (E.R.K.)
In Brief
Mouse CPEB3 is a translational regulator
implicated in long-term memory
maintenance. Stephan et al. show that
CPEB3 is a functional prion and that
CPEB3 interaction with actin is essential
for prion formation. They also find that
actin mRNA is a CPEB3 target,
suggesting a positive regulatory loop
underlies CPEB3 function.
Cell Reports
ArticleThe CPEB3 Protein Is a Functional Prion
that Interacts with the Actin Cytoskeleton
Joseph S. Stephan,1,2 Luana Fioriti,1 Nayan Lamba,1 Luca Colnaghi,1,2 Kevin Karl,1 Irina L. Derkatch,1,*
and Eric R. Kandel1,2,3,*
1Department of Neuroscience, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA
2Howard Hughes Medical Institute, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA
3Kavli Institute for Brain Science, Columbia University, 1051 Riverside Drive, New York, NY 10032, USA
*Correspondence: irina.derkatch@gmail.com (I.L.D.), erk5@columbia.edu (E.R.K.)
http://dx.doi.org/10.1016/j.celrep.2015.04.060
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).SUMMARY
The mouse cytoplasmic polyadenylation element-
binding protein 3 (CPEB3) is a translational regu-
lator implicated in long-term memory maintenance.
Invertebrate orthologs of CPEB3 in Aplysia and
Drosophila are functional prions that are physiolog-
ically active in the aggregated state. To determine
if this principle applies to the mammalian CPEB3,
we expressed it in yeast and found that it forms
heritable aggregates that are the hallmark of known
prions. In addition, we confirm in the mouse the
importance of CPEB3’s prion formation for CPEB3
function. Interestingly, deletion analysis of the
CPEB3 prion domain uncovered a tripartite organi-
zation: two aggregation-promoting domains sur-
round a regulatory module that affects interaction
with the actin cytoskeleton. In all, our data provide
direct evidence that CPEB3 is a functional prion in
the mammalian brain and underline the potential
importance of an actin/CPEB3 feedback loop for
the synaptic plasticity underlying the persistence
of long-term memory.
INTRODUCTION
Prions are self-perpetuating protein conformers that were initially
identified as the agents of transmissible spongiform encepha-
lopathies (Prusiner, 1982), and growing evidence suggests that
prion-like mechanisms also underlie a variety of neurodegenera-
tive disorders, including Alzheimer’s, Huntington’s, and Parkin-
son’s diseases (Jucker and Walker, 2013). However, not all
prions are pathogenic. Functional prion-like proteins and amy-
loids have now been described in various organisms from bacte-
ria to mammals, suggesting that biologically useful prions may
be ubiquitous in nature (Newby and Lindquist, 2013).
In addition to domains responsible for their cellular function,
most prion proteins contain distinct prion domains that mediate
a conformational switch to the aggregated, prion form of the pro-
tein (Du, 2011). Prion domains, which are frequently glutamine
(Q) and asparagine (N) rich, can be complex and encompass1772 Cell Reports 11, 1772–1785, June 23, 2015 ª2015 The Authorsdistinct modules, which act cooperatively in prion formation
(Kadnar et al., 2010; Tessier and Lindquist, 2007).
While the switch to the prion state occurs stochastically for
pathological prions, functional prion formation appears to be
tightly regulated and induced upon specific physiological stimuli.
For example, appearance of the yeast prions [PSI+] and [MOT3+]
occurs in response to environmental stress (Holmes et al., 2013;
Tyedmers et al., 2008), and in Aplysia, prion-like aggregation of
the translational regulator cytoplasmic polyadenylation element
binding protein (CPEB) is induced by serotonin and is important
for themaintenance of long-termmemory (Si et al., 2003a, 2010).
The cellular mechanisms underlying long-term memory stor-
age involve sustained synaptic modification and the growth of
new synaptic connections, which are in turn dependent upon
the local translation of specific mRNAs (Bailey and Kandel,
1993). To explain how synaptic specificity could be achieved, it
was proposed that neurons could restrict de novo translation
to activated synapses by means of a specific ‘‘tag’’ for the ‘‘cap-
ture’’ of necessary mRNAs, thus ensuring the localized transla-
tion essential for long-term memory storage (Martin et al.,
1997). This idea has been supported by the characterization of
the functional prion CPEB in Aplysia and its Drosophila homolog
Orb2 (Majumdar et al., 2012; Si et al., 2010). Indeed, CPEB fulfills
the proposed properties of a synaptic tag: (1) it is activated by
synaptic stimulation; (2) it is spatially restricted by prion aggrega-
tion; and (3) its self-perpetuating prion nature constitutes a
molecular basis for the maintenance of synaptic facilitation
underlying long-term memory storage.
These findings in invertebrates have led us to investigate their
applicability to mammals. The mammalian CPEB family includes
CPEB1, 2, 3, and 4, of which CPEB3 is the best candidate for the
ortholog of CPEB. Indeed, in addition to two RNA-binding do-
mains at its C terminus (Theis et al., 2003), CPEB3 possesses
a Q-rich N-terminal domain that resembles the CPEB prion
domain. Furthermore, work from our lab has identified a role
for the CPEB3 Q-rich domain in the maintenance of long-term
memory (Pavlopoulos et al., 2011), suggesting that a prion-like
mechanism must be the basis of CPEB3 function in memory
persistence (Fioriti et al., 2015).
Here, we have directly tested the hypothesis that the aggre-
gated form of CPEB3 is a functional prion. We find that in yeast,
CPEB3 forms heritable aggregates with the biochemical and
microbiological hallmarks of known prions. In addition, we find
that bacterially expressed CPEB3 forms amyloid fibers typical of
known prions, and CPEB3 in the mouse forms aggregates that
are increased upon stimulation. Serial deletion analysis revealed
a tripartite organization for the CPEB3 prion domain: two coop-
erative, aggregation-promoting elements surround a central
module that regulates interaction with the actin cytoskeleton.
Indeed, we found that CPEB3 interacts with actin in yeast
and mouse synapses and that CPEB3 aggregation is in
fact dependent on an intact actin cortical cytoskeleton.
Moreover, we find that a domain essential for CPEB3 prion for-
mation is required for CPEB3’s activation of its targets important
for long-term memory maintenance. Finally, we identify actin
as a CPEB3 target in the mouse brain, and we demonstrate
that stimulation-induced CPEB3 prion formation modulates
actin mRNA levels. Thus, our findings suggest that CPEB3 is
a functional prion that interacts with actin to constitute a
positive feedback loop important for memory persistence in
mammals.
RESULTS
CPEB3 Forms Foci in Yeast that Have the Features of
Well-Characterized Fungal Prions
The budding yeast Saccharomyces cerevisiae is an excellent
model for the study of endogenous and heterologous prions (Al-
berti et al., 2010; Li et al., 2014; Si et al., 2003b). We therefore
investigated whether CPEB3, when expressed in yeast, had
the hallmarks of known prions. Specifically, we asked whether
CPEB3 retained the ability to aggregate previously described
in yeast for its invertebrate homolog (Si et al., 2003b). To monitor
CPEB3 aggregation, we generated an inducible construct similar
to a construct used for the yeast prion-forming protein, Sup35
(Patino et al., 1996): the CPEB3 and yellow fluorescent protein
(YFP) fusion was placed under the control of the copper-induc-
ible promoter from the yeast CUP1 gene. De novo induction of
CPEB3-YFP expression (Figure 1A) in the [pin][psi] derivative
of the 74-D694 strain did not result in any growth defect (Fig-
ure 1B) and led to the formation of bright fluorescent foci; by
contrast, cells expressing YFP alone always exhibited a diffuse
cytoplasmic signal (Figure 1A). The CPEB3 foci were mostly
observed at the cell periphery, and their number ranged from
one to several foci per cell, with most cells containing four or
fewer visible dots (Figures 1A and S1A).
Although CPEB3 localization has not been studied exten-
sively, we reasoned that since CPEB3 is an RNA-binding protein,
it might normally be present in RNA storage and turnover organ-
elles, such as P-bodies and stress granules. We therefore co-ex-
pressed CPEB3 and Dcp2, a marker for P-bodies and stress
granules in yeast (Buchan et al., 2008), and found that most
CPEB3 foci indeed colocalized with Dcp2 (Figure 1C). This result
confirmed that CPEB3 expressed in yeast was ‘‘functional’’ to
the extent that it could still interact with the RNA machinery,
and it suggested that CPEB3 foci were physiological rather
than products of spurious aggregation.
De novo formation of [PSI+] and other prions is greatly
enhanced by passage from the logarithmic to the stationary
phase of yeast growth (Li et al., 2014; Zhou et al., 2001) (see Fig-
ure 1B legend). To test whether the formation of CPEB3 foci wasCealso growth-phase dependent, we induced CPEB3 expression
in freshly diluted cultures and monitored the distribution of fluo-
rescence over time. At 26 hr after the start of induction (ASI), a
time point corresponding to mid-log phase (Figure 1B) and
when a majority of cells exhibited a strong fluorescent signal,
CPEB3 foci appeared in only 10% of cells (Figures 1D and
1E). In contrast, at 32 hr ASI (corresponding to late-log phase),
punctate CPEB3 fluorescence was observed in 40% of cells,
and at 48 hr ASI (corresponding to early stationary phase), the
percentage of foci-containing cells peaked at more than 80%
(Figures 1D and 1E). To further investigate this dependence
on growth phase, we induced CPEB3 expression in freshly
diluted cultures and maintained the cells in early to mid-log
phase by periodically diluting the cultures to prevent them
from reaching saturation. Compared to undiluted controls that
were allowed to enter stationary phase normally, a significantly
lower proportion of cells in the perpetually diluted cultures
harbored bright CPEB3 foci after 48 hr of growth (Figure 1F).
Thus, foci formation, while not strictly growth-phase dependent,
is nevertheless significantly enhanced by entry into late-log/
early stationary phase. In support of this finding, we detected
CPEB3 foci in more than 30% of cells as soon as 12 hr ASI
when we first allowed freshly diluted cultures to grow and enter
stationary phase in the absence of added copper, and only then
induced CPEB3-YFP expression (Figure 1F, compare with 26-hr
time point in Figure 1E).
Biochemical Characterization of CPEB3 Reveals Its
Propensity to Form Amyloid In Vitro in Yeast and Mice
The self-perpetuating properties of most prions are dependent
on the formation of an amyloid aggregate (Shorter and Lindquist,
2005). To determine whether CPEB3 possesses a propensity for
aggregation, we asked whether bacterially expressed, purified
CPEB3 protein could assemble into amyloid fibers in vitro.
Indeed, purified CPEB3 exhibited strong staining with the
amyloid-binding dye Congo red (CR) (Figure 2A). Furthermore,
when viewed under polarized light, the CR-stained CPEB3 ap-
peared as short fibrils that exhibited green birefringence (Fig-
ure 2A), strongly indicative of amyloid cross-b sheet quaternary
structure (Steensma, 2001). In contrast, neither CR staining nor
birefringence could be observed for similar concentrations of
bacterially expressed CPEB1, which lacks a prion-like domain
(Figure 2A; data not shown).
Consistently, transmission electron microscopy (TEM) anal-
ysis revealed that purified CPEB3 formed long non-branching fi-
brils similar to amyloid fibers formed by other prions. Individual
fibrils were 10 nm wide, could reach several micrometers in
length, and were usually bundled together into cords of variable
thickness (Figure 2B). Interestingly, CPEB3 occasionally coa-
lesced into ordered, mesh-like macroassemblies of short fibers
(Figure S2A). By contrast, we could not observe any fibers for
CPEB1, 2, and 4 (not shown). These results confirmed that
CPEB3 is able to attain the aggregated amyloid state typical of
most known prions.
Next, and to characterize the CPEB3 aggregates that form in
yeast, we used semi-denaturing detergent agarose gel electro-
phoresis (SDD-AGE) (Kryndushkin et al., 2003). This assay ex-
ploits the fact that prions run as SDS-resistant oligomers inll Reports 11, 1772–1785, June 23, 2015 ª2015 The Authors 1773
Figure 1. CPEB3-YFP Forms Foci in Yeast
(A) Left: confocal microscopy analysis of CPEB3-
YFP foci formation at 48 hr after the start of CPEB3
induction (ASI), in the [pin] derivative of the 74-
D694 yeast strain (see Experimental Procedures).
Right: anti-GFP immunoblot for expression of
CPEB3-YFP and YFP alone. In this panel and
hereafter, molecular weights are indicated in kilo-
daltons, unless otherwise stated.
(B) Growth curves of cells harboring CPEB3-YFP
or YFP alone, as a function of culture density
versus time ASI. Growth of yeast in liquid can be
delineated into three phases: an initial lag phase
where yeast are not growing, a logarithmic (log)
phase where yeast rapidly multiply, and a sta-
tionary phase where saturated cultures stop
growing. Shown is average optical density ± SE for
three independent cultures at each time point (Avg
OD600 ± SE; n = 3). Lag, log, and late-log to sta-
tionary phases are indicated.
(C) Colocalization of YFP and CPEB3-YFP with
Dcp2-CFP. Pseudo color was used for Dcp2-CFP
to enhance overlay visibility. Colocalization is de-
noted by yellow signal in the overlay panels.
CPEB3 overexpression did not affect Dcp2
localization.
(D) Confocal analysis of the time course of CPEB3-
YFP foci formation. Images were taken at the
indicated time points ASI.
(E) Statistical analysis of the time dependence
of CPEB3 foci formation plotted as Avg ± SE
(n = 3).
(F) Confocal analysis of the formation of CPEB3
foci in undiluted, diluted, and delayed induction
cultures for CPEB3-YFP fluorescence. Imaging
was at 48 hr ASI for diluted and undiluted cultures.
For the delayed induction cultures, after dilution to
OD600 0.1, cells were grown for 48 hr to allow
entry into stationary phase, then CPEB3 expres-
sion was induced and the cells were imaged at
12 hr ASI. Statistical analysis (Avg ± SE, n = 3) is
indicated.
See also Figure S1.semi-denaturing agarose gels and can thus be distinguished
from disordered aggregates that disassemble under these con-
ditions. Indeed, we found that CPEB3 segregated as a large-mo-
lecular-weight smear indicative of prion-like oligomers, similar to
Sup35 in [PSI+] prion-containing cells (Figure 2C). This finding
provides additional support for the prion nature of CPEB3, as
these oligomers are thought to be equivalent to prion seeds
(Kryndushkin et al., 2003). CPEB3 oligomers were resistant to
boiling (not shown), a feature consistent with the boiling resis-
tance of oligomers formed by the Drosophila CPEB3 ortholog
Orb2 (Majumdar et al., 2012), and also observed for huntingtin
(Hazeki et al., 2000). Interestingly, CPEB3 oligomers could be
detected prior to the appearance of the fluorescent CPEB3
foci (Figure S2B), suggesting that visible foci were not strictly
equivalent to prion seeds and could constitute a later step in1774 Cell Reports 11, 1772–1785, June 23, 2015 ª2015 The AuthorsCPEB3 aggregation. Finally, treatment of the CPEB3 aggregates
with RNase A did not affect their mobility on SDD-AGE, suggest-
ing that CPEB3 oligomerization does not depend on the binding
of CPEB3 to its target mRNAs (Figure S2C).
Next, we validated our findings in the mouse. Specifically, we
asked whether an increase in CPEB3 levels similar to that
causing aggregation in yeast would lead to CPEB3 aggregation
in mouse cells and whether this increase in CPEB3 levels could
be achieved by physiological stimuli relevant to CPEB3 func-
tion. As CPEB3 function is required for memory maintenance
(Pavlopoulos et al., 2011), we tested if stimulation of neurons
with glutamate, the brain’s main excitatory neurotransmitter,
led to an increase in CPEB3 levels. We found that such stim-
ulation led to an overall increase in CPEB3 levels, which corre-
lated with enrichment in aggregated CPEB3 (Figure 2D). This
Figure 2. CPEB3 Forms Prion-like Aggre-
gates In Vitro and In Vivo
(A) Congo red (CR) staining and green birefrin-
gence (BR) of CR-stained purified CPEB3. Boxed
areas are from a Coomassie-stained gel showing
the final amounts of CPEB1 and CPEB3 used in
the CR and BR assays.
(B) Left: transmission electron micrograph of
CPEB3 fibers. Right: magnification of the boxed
area of the left panel. Red arrows point to indi-
vidual CPEB3 fibrils.
(C) SDD-AGE analysis comparing oligomers
formed by CPEB3-3HA and the [PSI+] prion.
To detect [PSI+] oligomers, a CUP1-driven
Sup35NM-CFP construct was introduced into a
weak [PSI+] strain. CPEB3-3HA expression was
induced by addition of 100 mM CuSO4 to the me-
dium for 2 hr prior to analysis. Both proteins were
segregated on the same gel. After transfer, the
polyvinylidene fluoride membrane was cut, and
the resulting pieces were blotted with anti-GFP
and anti-HA antibodies for Sup35NM-CFP and
CPEB3, respectively. Molecular weight is indi-
cated based on the size of Sup35NM monomers
and ‘‘weak’’ [PSI+] oligomers (Kryndushkin et al.,
2003; Li et al., 2014).
(D) Differential centrifugation assay for CPEB3
aggregation. Proteins were extracted from neu-
rons stimulated with glutamate or mock treated
with mild detergent. Lysates were centrifuged to
separate soluble and aggregated fractions, and
supernatant (S) and pellet (P) were analyzed by
western with anti-CPEB3 antibody. GAPDH was
used as loading control.
(E) SDD-AGE analysis of the effect of neuronal
stimulation on CPEB3 oligomerization in the
mouse brain. Animals were injected with kainate
and sacrificed after 15 min for protein extraction
and processing. Equal amounts of total protein
determined by BCA were loaded on the gel;
amounts of CPEB3 in the samples are not equal
because CPEB3 levels increase upon stimulation
(see Figure 2D). See Figure S2D for quantification.
(F) Top: schematic of the INI assay for heritability
of CPEB3 aggregates. Pre-cultures grown in
plasmid-selective SD-Ura medium for 2 days were
diluted to OD600 0.1 into either SD-Ura + 50 mM
CuSO4 (INI, right, Induction) or SD-Ura without excess copper (NNI, left, No induction). After 48 hr of growth, all cultures were diluted to OD6000.1 into SD-Ura
without excess copper and grown for 2 days (seven or eight generations; No induction). Finally, all cultures were diluted toOD6000.1 into SD-Ura + 50 mMCuSO4
(Induction), andCPEB3 aggregation was analyzed 18 hr later. Second panel: Images of representative groups of cells for theNNI and the INI conditions. Statistical
analysis is included (Avg ± SE, n = 3). Third panel: anti-GFP immunoblots showing the corresponding CPEB3-YFP expression levels at the end of each step in the
assay.
(G) Confocal analysis of CPEB3-YFP foci formation in wild-type and hsp104-D cells. Imaging was at 48 hr ASI. Statistical analysis is shown (Avg ± SE, n = 3).
See also related Figure S2.activity-dependent increase in CPEB3 levels could well be the
mechanism that leads to CPEB3 prion formation in vivo. To
test if CPEB3 aggregates forming upon neuronal stimulation
were indeed prion-like, we injected mice with the potent gluta-
mate agonist, kainic acid (Moloney, 1998) and analyzed hippo-
campal homogenates by SDD-AGE. Indeed, CPEB3 formed
SDS-resistant oligomers in kainic-acid-stimulated mice (Figures
2E and S2D). Strikingly, SDS-resistant CPEB3 oligomers were
detected in mouse hippocampi even in the basal state, but while
total CPEB3 levels went up upon stimulation, there was a higherCespecific increase of the CPEB3 oligomers compared to the in-
crease in CPEB3 monomer (Figures 2E and S2D).
The CPEB3 Aggregates Formed in Yeast Are Heritable,
and Their Formation Is Modulated by Hsp104
In yeast, the ability of prions to self-perpetuate is manifested
by transmission of the prion state from mother to daughter cells,
a process facilitated by the chaperone machinery. To obtain
further evidence for CPEB3’s prion nature, we asked whether
CPEB3 aggregates were similarly heritable, using a stringentll Reports 11, 1772–1785, June 23, 2015 ª2015 The Authors 1775
Figure 3. N-Terminal Deletion Analysis Identifies Domains Essential for CPEB3 Foci Formation, Foci Heritability, and Prion-like Oligo-
merization
(A) Schematic diagram of CPEB3 (not to scale). Numbers refer to amino acid positions. Q, glutamine rich; P/Q, proline/glutamine rich; A/S, alanine/serine rich;
V/G, valine-glycine dipeptide repeats; RBD, RNA-binding domains. Predicted secondary structure elements are denoted in red: H, helix; S, strand. The 1–449
region of CPEB3 is unstructured. The 1–217 region bears the majority of the Q and P content of CPEB3, including a short Q-rich tract (1–32), two P/Q-rich
stretches (aa 89–98 and 167–191), and a relatively high-P/Q-content region (191–217). The 217–284 region is predicted to be buried and features unusual
sequence elements: an A/S-rich tract (aa 226–239) and poly-V/G repeats (aa 273–283). The 284–449 region bears multiple helical motifs. The first CPEB3 RNA-
binding domain begins at aa 459 (not pictured).
(B) Schematic of the CPEB3-YFP N-terminal deletion constructs with structural motifs and sequence elements. Color-coding corresponds to (A).
(C) Anti-YFP immunoblot showing expression products of the N-terminal deletion constructs.
(D) Analysis of foci formation in cells expressing CPEB3-YFP and the N-terminal deletion constructs. Imaging was at 48 hr ASI. Statistical analysis is shown
(Avg ± SE, n = 3).
(legend continued on next page)
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microscopy-based heritability assay previously used for the Tia1
prion and [PSI+] (Li et al., 2014). In this ‘‘induction-no induction-
induction’’ (INI) assay (see right in the diagram in Figure 2F),
CPEB3 aggregation was first induced by growing cultures for
48 hr in the presence of 50 mm CuSO4. Cultures were checked
by microscopy for CPEB3 foci formation, then diluted into
medium lacking added copper and allowed to grow for several
generations. The rationale was that the low amounts of copper
normally found in this medium, while unable to induce de novo
CPEB3 aggregation due to very low expression of the protein
(see Figure 2F, bottom), should still be sufficient for maintenance
of the aggregated conformation if it were indeed self-perpetu-
ating. Finally, the cultures were transferred into the inducing
mediumwith 50 mmCuSO4, and the rate of CPEB3 foci formation
was compared to the control cultures, in which CPEB3 ex-
pression was induced only once, at the final stage (‘‘no induc-
tion-no induction-induction’’ [NNI]; see left in the diagram in
Figure 2F). As seed nucleation is the rate-limiting step in prion
formation (Come et al., 1993; Serio et al., 2000), transmission
of CPEB3 prion seeds during the ‘‘no induction’’ step was ex-
pected to result in earlier appearance of visible aggregates dur-
ing the final ‘‘induction’’ step in the INI cultures. Indeed, we found
that more than 70%of the INI cells had fluorescent CPEB3 foci at
18 hr after the final induction, compared to less than 5% of the
NNI control cells, even though we observed no difference in
the levels of CPEB3 expression between INI and NNI cultures
at this time-point (Figure 2F), and the mean fluorescence inten-
sities were similar between the two conditions (Figure S2E).
This finding indicated that a ‘‘trace’’ of the initial induction had
been maintained and propagated across several generations
of yeast cells and strongly suggested that CPEB3 formed herita-
ble, self-perpetuating prion seeds.
The propagation of most yeast prions depends on the Hsp104
chaperone (Reidy and Masison, 2011). To test whether CPEB3
foci formation displayed a similar dependence, we expressed
CPEB3-YFP in an isogenic strain lacking Hsp104 (hsp104-D)
and analyzed CPEB3 foci formation at 48 hr ASI. While lack of
Hsp104 did not fully block the formation of CPEB3 aggregates,
we found an 2-fold decrease in the number of cells with
CPEB3 foci in hsp104-D cells compared to the wild-type control,
and hsp104-D foci were generally less bright (Figure 2G). Inter-
estingly, similar results have been reported for the gain-of-func-
tion prions [Het-s] and CPEB, both of which only display a partial
dependence on the Hsp104 chaperone (Malato et al., 2007; Si
et al., 2003b).
N-Terminal Deletion Analysis of CPEB3 Identifies the
Domain Important for CPEB3 Foci Formation
The two CPEB3 functional RNA-binding domains (RBDs) begin
at aa 459 and extend toward the C-terminal end of the protein(E) INI heritability assay for the N-terminal CPEB3-YFP deletion series. Heritabilit
CPEB3-1–191D-YFP and CPEB3-1–167D-YFP, and at 18 hr ASI for CPEB3-FL-Y
(F) Anti-HA immunoblots (IB) of SDD-AGE analysis comparing oligomers formed b
referred to by amino acid number. Cells harboring the indicated constructs were i
FL lane is a common CPEB3 proteolytic product. Bottom image is an anti-HA
constructs were determined from serial-dilution westerns (data not shown) and l
See also related Figure S3.
Ce(Figure 3A). Moreover, sequence comparisons reveal that the
CPEB3 region downstream of aa 449 is virtually identical be-
tween CPEB3 and other members of the CPEB family. Since,
for most prions, functional domains and prion domains are
distinct, we reasoned that the N-terminal region composed of
aa 1–449 was the most likely candidate for a CPEB3 prion
domain, and we focused our deletion coverage on that portion
of the protein. To mark salient structural features of CPEB3
(Figure 3A and legend), we performed an in silico analysis
(http://toolkit.tuebingen.mpg.de/quick2_d) and generated two
series of sequential deletions, the N-terminal and the C-termi-
nal series (see Table S1). The five N-terminally deleted,
CUP1-driven constructs, designed so as not to interrupt pre-
dicted secondary structure motifs, were: (1) CPEB3-1–167D-
YFP, lacking the first Q-rich stretch (aa 1–32), and the first
P/Q-rich tract (aa 89–98); (2) CPEB3-1–191D-YFP, also
lacking the second P/Q-tract but retaining the last P/Q-rich
tract; (3) CPEB3-1–217D-YFP, completely lacking the Q- and
P/Q-rich sequences; (4) CPEB3-1–284D-YFP, which lacks the
entirety of the Q- and P/Q-rich sequences as well as the A/S-
rich tract and VG dipeptide repeats; and finally, (5) CPEB3-1–
449D-YFP, which only contains the RNA-binding domains
(Figure 3B).
For these constructs, proteins of the predicted size were ex-
pressed (Figure 3C) without significant growth inhibition, except
for CPEB3-1–284D-YFP, which caused a mild growth defect
(Figure S3A). We next compared the foci-forming ability of these
N-terminal deletions with that of the full-length CPEB3-YFP at
48 hr ASI. Consistent with the CPEB3 prion domain being sepa-
rate from the RBD region, foci formation was severely impaired
for the CPEB3-1–449D-YFP construct (Figure 3D). Indeed, while
occasional cytoplasmic fluorescent dots were still observed,
CPEB3-1–449D-YFP dots generally appeared less sharp and
amorphous, with a considerable amount of the protein still
distributed throughout the cytoplasm. Importantly, these rare
CPEB3-1–449D-YFP dots still colocalized with Dcp2, suggest-
ing that the defect in foci formation was not due to compromised
interaction with RNA-processing compartments (Figure S1B).
Given that cells expressing all the other constructs, including
CPEB3-1–284D, displayed bright foci at 48 hr ASI (Figure 3D),
we concluded that region 284–449 of CPEB3 was necessary
for foci formation.
N-Terminal Deletion Analysis of CPEB3 Reveals
Sub-domains Important for Foci Distribution and
Speed of Formation
Interestingly, foci morphology and rate of appearance differed
drastically among the remaining deletions, suggesting that the
284–449 region was not the only modulator of CPEB3 aggrega-
tion. While CPEB3-1–167D-YFP and CPEB3-1–284D-YFP fociy was determined as shown in Figure 2F at 12 hr ASI for CPEB3-1–167D-YFP,
FP and CPEB3-1–449D-YFP. Statistical analysis is shown (Avg ± SE, n = 3).
y the full-length CPEB3-3HA protein (FL) and the indicated N-terminal deletions,
nduced for 2 hr with 100 mMCuSO4 prior to harvesting. The bottom band in the
western IB showing equal loading. Equal amounts of protein for the different
oaded on both the anti-HA western IBs and the SDD-AGE gel.
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distribution was indistinguishable from that of the full-length pro-
tein (Figure 3D), CPEB3-1–191D-YFP and CPEB3-1–217D-YFP
foci decorated the cell periphery in bright, densely dotted rims
(Figure 3D), the distinct nature of which was further underscored
by the fact that most of these foci did not co-localize with Dcp2
(Figure S1C). This striking localization pattern was not an emer-
gent property of the deletion constructs, as it could occasionally
be seen in cells expressing the full-length CPEB3 protein (Fig-
ure S1D). Rather, this change in distribution most likely reflected
the unmasking of a natural CPEB3 propensity, resulting from
exposure of a normally buried regulatory domain (aa 217–284;
see Figure 3A legend) and/or alleviation of an inhibitory effect
on rim formation by the N-terminal-most portion of the protein.
Several lines of evidence support this interpretation. First,
dotted rims were never observed for CPEB3-1–284D-YFP and
CPEB3-1–449D-YFP, suggesting that region 217–284 is neces-
sary for dotted rim distribution. Second, dotted rims formed
by the CPEB3-1–217D-YFP construct were noticeably better
defined than those formed by the CPEB3-1–191D-YFP con-
struct, indicating that the region 191–217 retained a modest
inhibitory effect on rim formation (Figure 3D). Third, the relative
speed of foci formation among the CPEB3-1–167D-YFP, the
CPEB3-1–191D-YFP, and the CPEB3-1–217D-YFP constructs
was incrementally proportional to deletion size, reflecting a pro-
gressive decrease in the dependence on growth phase observed
for full-length CPEB3. Indeed, while CPEB3 foci normally appear
in less than 10% of cells in early or mid-log phase, CPEB3-1–
167D-YFP foci could be detected in 90% of cells at mid-log,
and CPEB3-1–191D-YFP and CPEB3-1–217D-YFP foci ap-
peared in early log in 30% and 90% of cells, respectively (Fig-
ure S3B). In fact, CPEB3-1–217D-YFP foci were observed in
most cells as soon as fluorescence could be detected (not
shown).
Interestingly, the rate of foci formation appeared to peak
with CPEB3-1–217D-YFP and subsequently taper off for the
larger deletions CPEB3-1–284D-YFP and CPEB3-1–449D-YFP.
Indeed, CPEB3-1–284D-YFP foci were not present in early log
but appeared in most cells by mid-log, and the occasional
CPEB3-1–449D-YFP foci only appeared in late-log/stationary
phase (Figure S3B). Although it is tempting to correlate this
decrease in rate of foci formation with the absence of region
217–284, these last results should be interpreted with caution,
as CPEB3-1–284D-YFP causes a growth defect that could
impact kinetics of foci formation, and CPEB3-1–449D-YFP is
severely defective in foci formation.
N-Terminal Deletion Analysis of CPEB3 Underlines
Sub-domains Essential for Prion-like Oligomerization
and Heritability
Next, we tested heritability of the CPEB3-YFP deletion con-
structs with the INI assay (see Figure 2F). Given that foci forma-
tion was dramatically accelerated for most deletions and
aggregate-containing cells accumulated in the NNI control by
24 hr, we shortened the length of the final induction to 12 hr
for all the remaining deletions, with the exception of CPEB3-
1–449D-YFP. This was the earliest time point at which fluores-
cence levels were appropriate for conclusive analysis (not
shown). We found that INI cells expressing CPEB3-1–167D-1778 Cell Reports 11, 1772–1785, June 23, 2015 ª2015 The AuthorsYFP were still able to maintain prion-like seeds during the
non-induction step, allowing for a rapid re-assembly of visible
foci (Figure 3E). However, heritability of CPEB3-1–167D-YFP
was significantly decreased compared to the full-length
CPEB3-YFP protein, suggesting that the first 167 amino
acids of CPEB3 were implicated in CPEB3 foci heritability.
For the shorter constructs CPEB3-1–191D-YFP, CPEB3-1–
284D-YFP, and CPEB3-1–449D-YFP, there was no significant
difference in the timing of foci formation between the INI and
NNI cultures (Figure 3E). While we cannot exclude the possibil-
ity that residual heritability of CPEB3-1–191D-YFP foci was
masked by rapid aggregation, the simplest interpretation of
this result is that deletion of the N-terminal part of the protein
encompassing Q- and P/Q-rich sequences results in a loss of
the heritability of CPEB3 aggregates. For the CPEB3-1–
217D-YFP construct, heritability analysis was impossible, as
it formed foci as soon as fluorescence could be detected
(not shown).
Next, we tested the N-terminal deletions by SDD-AGE and
found that formation of oligomers was partially compromised
for CPEB3-1–167D, as well as for a slightly shorter CPEB3-1–
157D construct (Figure 3F). Oligomerization was essentially
abolished for CPEB3-1–191D (Figure 3F) and for all shorter con-
structs tested, including CPEB3-1–217D and CPEB3-1–449D
(Figure S3C). These findings were confirmed in mammalian cells
(Figure S3D) and further supported by the fact that bacterially
expressed CPEB3-1–217D did not stain with CR, nor did it
form fibers detectable by electron microscopy (data not shown).
In all, our data indicate that region 1–217 is essential for CPEB3’s
ability to form heritable oligomer-based aggregates in vivo and
amyloid fibers in vitro.
C-Terminal Deletion Analysis of CPEB3 Reveals a
Tripartite Architecture of the CPEB3 Prion Domain
To complement the N-terminal deletion analysis of CPEB3, we
generated a C-terminal deletion series based on a full-length,
CUP1-driven CPEB3-6MYC construct (Figure 4A). Expression
of these constructs in yeast resulted in no noticeable growth
defect (data not shown). When tested in the SDD-AGE
assay (Figure S4A), deletion of aa 284–716 and subsequently
larger deletions led to a virtually complete loss of the
oligomerization smear seen with full-length CPEB3-6MYC.
This result corroborated our previous finding that aa 284–449
were essential for CPEB3 foci formation (see Figure 3D).
Consistently, foci analysis in cells with a CFP-tagged version
of the CPEB3-284–716D deletion showed that CPEB3-284–
716D-CFP was severely compromised in foci formation
compared to full-length CPEB3-CFP and CPEB3-449–716D-
CFP (Figure S4B). Interestingly, a short CPEB3-32–716D-
6MYC construct consisting of only the first 32 aa of CPEB3
(but containing the longest poly-Q stretch of the protein) was
extremely efficient at forming SDS-resistant oligomers on its
own (Figure S4A), reflecting the fact that the first 32 aa are
important, but not sufficient, for prion-like ‘‘smearing’’ in the
context of the full-length CPEB3 or longer constructs. It also
suggested that CPEB3 aggregation results from the coopera-
tive action of the N-terminal Q-rich stretch and downstream
CPEB3 domains.
Figure 4. C-Terminal Deletion Analysis of
CPEB3 and the Role of CPEB3 Prion Forma-
tion in the Mouse
(A) Schematic diagram of the C-terminal, 6MYC-
tagged CPEB3 deletion series (not to scale).
Secondary structure elements and relevant
domains are noted. Ability to form oligomers as-
sayed by SDD-AGE is summarized. The CPEB3-
271–716D-6XMYC and CPEB3-74–716D-6XMYC
constructs are not shown (see Figure S4A).
(B) Confocal analysis of the dependence of stim-
ulation-induced upregulation of CPEB3 target
GluR2 upon the CPEB3 1–217 domain essential
for prion formation. 16–20 hr post-transfection,
cells were briefly stimulated with 200 mM glutamic
acid, washed with growth media, and incubated
for 30 min to 1 hr, then fixed with 4% para-
formaldehyde and imaged.
See also related Figure S4.In summary, deletion analysis of the CPEB3 prion domain re-
vealed a tripartite organization with complex interactions (see
Figure 7A): the first domain encompassing aa 1–191/217 (here-
after referred to as PRD1) is essential for prion seed formation
and foci heritability, the second domain between aa 191/217
and 284 (LMD) is a regulatory domain that mediates CPEB3’s
dotted rim distribution, and the third domain from aa 284 to
449 (PRD2) is essential for CPEB3 foci formation.
Importance of the CPEB3 PRD1 Domain for CPEB3
Function in Mice
Analysis in yeast and in vitro suggested that CPEB3 domain
PRD1 was essential for prion-like aggregation. To test the role
of prion formation in CPEB3 function in the mouse, we looked
at the effect of PRD1 deletion on CPEB3’s ability to promote
increased expression of its target, GluR2 (Huang et al., 2006;
Pavlopoulos et al., 2011), upon glutamatergic stimulation.Cell Reports 11, 1772–178In neurons transfected with full-length
CPEB3, expression of CPEB3 in the
absence of stimulation led to a decrease
in GluR2 levels (Figures 4B and S4C),
consistent with earlier reports that
CPEB3 acts as a repressor of translation
in the basal state (Huang et al., 2006).
However, stimulation with glutamate re-
sulted in formation of CPEB3 foci similar
to those we had observed in yeast and
led to an increase in the levels of
CPEB3 target GluR2 (Figures 4B and
S4C). This increase occurred even in
the absence of CPEB3 overexpression,
likely due to endogenous CPEB3 (Fig-
ure S4C). By contrast, transfection of a
truncated CPEB3 lacking PRD1 resulted
in a loss of the CPEB3-mediated, sti-
mulation-dependent increase in GluR2
levels (Figures 4B and S4C). Thus, we
conclude that CPEB3’s PRD1 domain,
which is essential for CPEB3 prionbehavior, is also essential for the activity-induced upregulation
of GluR2 that is essential for the synaptic plasticity at the basis
of memory persistence.
CPEB3 Interacts with Actin and CPEB3 Aggregates
Colocalize with the Actin Cytoskeleton in Yeast and
Mice
The peripheral cellular distribution of CPEB3-YFP aggregates
and the peripheral rims formed by some deletion constructs
strikingly resemble structures associated with the cortical actin
cytoskeleton in yeast (Welch et al., 1994). To test whether
CPEB3 indeed interacts with actin in yeast, we used an unbiased
mass spectrometry (MS) approach (Applied Biomics) to iden-
tify CPEB3 partners that may contribute to its cellular distribu-
tion. We induced expression of the CPEB3-3HA construct in
yeast for 48 hr, then performed an anti-HA pull-down and
submitted the immunoprecipitated complexes to nano-liquid5, June 23, 2015 ª2015 The Authors 1779
Figure 5. CPEB3 Interacts with Actin in
Yeast and Mice
(A) Known actin- or actin cytoskeleton-interacting
proteins among the 50 highest-confidence hits
(excluding actin itself) from MS analysis of CPEB3
immunoprecipitates in yeast.
(B) Coimmunoprecipitation experiment frommouse
hippocampi showing CPEB3 and actin interaction
(redarrowpoints to actin).KO, immunoprecipitation
from the CPEB3 knockout mice; B, empty beads
control. The red asterisk denotes the antibody
chain.
(C) Immunohistochemistry experiments in yeast
cells expressing CPEB3-YFP or CPEB3-1–217D-
YFP reveal actin and CPEB3 colocalization. Actin
was stained with anti-actin antibody and CPEB3
with an anti-GFP antibody.
(D) Immunohistochemistry experiments on hippo-
campal neurons transfected with actin-GFP and
CPEB3-DsRed. The neurons were stimulated with
glycine before fixing and imaging. Panels 1, 2, and
3 are larger views of the boxed areas in the corre-
sponding panels. Yellow denotes colocalization in
the overlay panels.White arrowspoint to examples
of colocalizing actin and CPEB3 signals.
See also related Figure S5.chromatography-tandem mass spectrometry. Indeed, our anal-
ysis identified actin as an interacting partner of CPEB3. In fact,
19 out of the 50 highest confidence hits were proteins that are
known to physically or genetically interact with actin or compo-
nents of the actin cytoskeleton (Figure 5A).
Given that CPEB3 physically interacts with actin in yeast, we
next tested if CPEB3 foci colocalized with components of the
actin cytoskeleton. In yeast, actin forms two distinct cytoskeletal
structures: intracellular cables, and peripheral patches that
constitute the cortical actin cytoskeleton (Adams and Pringle,
1984). We performed co-staining for YFP and actin in meth-
anol-fixed yeast cells expressing CPEB3-YFP and CPEB3-1-
217D-YFP, and we found that CPEB3 foci partially colocalized
with actin patches for both those constructs (Figure 5C). These
results were corroborated in primary neuronal cultures, where
we similarly saw colocalization in cells cotransfected with
CPEB3 and a plasmid expressing actin at near-physiological
levels (Figure 5D).1780 Cell Reports 11, 1772–1785, June 23, 2015 ª2015 The AuthorsTo further confirm these results, we
tested in mice whether CPEB3 also
interacted with actin, at endogenous
levels of both proteins. Indeed, we found
that mouse actin could be detected in
CPEB3 immunoprecipitates prepared
from the hippocampi of wild-type mice
but not from immunoprecipitation (IP)
controls that lacked the anti-CPEB3 anti-
body or usedCPEB3KOmice (Figure 5B).
Finally, we asked whether the CPEB3/
actin interaction could be detected at
synapses. To that end, we prepared syn-
aptosomes frommouse neurons and per-formed co-IP experiments using anti-CPEB3 antibodies, and we
found that CPEB3 interacted with actin at synapses (Figure S5),
suggesting that the interactionwas physiologically relevant in the
neuronal context.
CPEB3 Aggregation Requires an Intact Actin
Cytoskeleton
To probe the relationship between CPEB3 foci formation and the
actin cytoskeleton, we induced expression of full-length CPEB3-
YFP and the N-terminally deleted CPEB3 constructs, and we
simultaneously treated the yeast cells with the actin-filament-de-
polymerizing drug latrunculin A (LatA). We found that LatA
treatment prevented foci formation in most cells for all the con-
structs tested (Figure 6A). For the few cells that still exhibited
foci, LatA treatment resulted in a profound alteration in foci dis-
tribution with the prevalence of atypical, intracellular dots rather
than the peripheral foci observed with the untreated controls
(Figure 6A).
To further confirm the dependence of CPEB3 aggregation
on the actin cytoskeleton, we used a genetic approach by ex-
pressing CPEB3-YFP in a number of yeast strains with deletions
of known components of the actin cytoskeleton. Compared
to the isogenic wild-type strains, CPEB3 foci formation was
severely impaired in the end3-D, rvs167-D, sla1-D, and sla2-D
mutants that have aberrant actin patch morphology (Figure 6B).
By contrast, CPEB3 foci formationwas not detectably affected in
the abp1-D cytoskeletal mutant that maintains normal actin
patch morphology (Figure 6B).
CPEB3 Binds Actin mRNA and Leads to a Stimulation-
Induced Increase in Actin Protein Levels
Given that CPEB had been found to bind actin mRNA (Si et al.,
2003a), and since b-actin contains two putative CPEB3-binding
sequences (see the Supplemental Experimental Procedures), we
used total mouse hippocampal RNA preparations to test by RT-
PCR if CPEB3 could bind actin mRNA. Indeed, we found that
CPEB3 bound actin mRNA, but not the control GAPDH mRNA
(Figure 6C).
We next asked if actin was a stimulation-induced target of
CPEB3, using a reporter system where the actin 30 UTR was
fused to the gene for Renilla luciferase. First, in HEK293 cells,
we found that the wild-type actin UTR co-transfected with
CPEB3 had a significantly lower luciferase activity than an
actin UTR with mutated CPEB3 consensus sites, showing the
specificity of CPEB3’s effect on actin translation and suggesting
that CPEB3 is a translational repressor of actin in the basal
state (Figure S6C). Next, we focused on neurons and found
that chemical stimulation of neurons with glycine led to a
CPEB3-dependent increase in luciferase activity (Figure 6D),
indicating that actin levels in vivo are upregulated in a CPEB3-
dependent manner following neuronal stimulation. Similar to
what we had observed with the previously characterized
CPEB3 target GluR2, deletion of the CPEB3 PRD1 domain led
to the loss of the CPEB3-mediated increase in actin levels
following stimulation, suggesting that CPEB3 prion formation is
important for this process.
DISCUSSION
In this study, we asked whether mouse CPEB3 possessed bona
fide prion properties, and we found that it indeed exhibits three
hallmarks of known prions: (1) the ability to form amyloid
in vitro that can be visualized as long fibers by TEM and detected
by birefringence in CR-stained samples, (2) the ability to form
SDS-resistant oligomers in yeast and the mouse, and (3) the
ability to form heritable foci in yeast that are modulated by
Hsp104.
We further characterized the CPEB3 prion by deletion anal-
ysis, which revealed a complex prion domain with a tripartite
organization (Figure 7A). The first and third domains, PRD1 and
PRD2, were required for CPEB3’s prion properties. PRD1 (aa
1–191/217) is essential for prion seed formation and foci herita-
bility. PRD2 (aa 284–449) is essential for CPEB3 foci formation.
Of these two domains, PRD1 has an amino acid composition
that is the most similar to that of other prions with Q-rich prion
domains: it contains an extremely Q-rich stretch (aa 1–32), twoCeP/Q-rich tracts (aa 89–98 and 167–191), and a region with a rela-
tively high P/Q content (aa 191–217) (Figure 3A).
Importantly, deletion of PRD1 in the mouse interfered with
CPEB3’s activation of its targets b-actin and GluR2, the AMPA
receptor critical for synaptic plasticity (Nayak et al., 1998). These
results, together with the previous finding that the CPEB3 Q-rich
N terminus mediates the positive effect of the ubiquitin-ligase
Neuralized on learning and memory (Pavlopoulos et al., 2011),
strongly suggest that CPEB3 is a functional prion and that
CPEB3 prion formation is necessary for CPEB3 function in the
context of long-term memory maintenance. Considering earlier
findings on the CPEB prion in invertebrates, our evidence for
CPEB3 as a functional prion in the mammalian brain suggests
that a CPEB-mediated, prion-based mechanism of regulation
of memory persistence is conserved in mammals. In that
context, it is worth mentioning that CPEB3 has been implicated
in episodic memory in humans (Vogler et al., 2009) and that
the CPEB3 prion-forming determinants identified here are
conserved in the human protein.
The middle region of the CPEB3 N terminus identified in
our deletion analysis, LMD (aa 191/217–284) (Figure 7A), is a reg-
ulatory domain that influences the distribution of CPEB3 along
the cell periphery and, specifically, the formation of character-
istic rims of CPEB3 foci. This region contains two unusual
sequence features, an extremely A/S-rich tract (aa 226–239)
and a run of VG dipeptide repeats (aa 273–283). The LMD is
the most intriguing part of the CPEB3 prion domain, as it consti-
tutes a central core located between two prion-promoting do-
mains and modulates a functional interaction with the actin
cytoskeleton.
This prion domain architecture, in addition to CPEB3
SUMOylation in the basal state (Drisaldi et al., 2015), could pro-
vide a possible explanation for why CPEB3 is a repressor of its
targets in the basal state and only switches to an activator
upon synaptic stimulation (Huang et al., 2006; Pavlopoulos
et al., 2011; Fioriti et al., 2015). Given that the two CPEB3 prion
determinants PRD1 and PRD2 are spatially separated, it is
possible that CPEB3 exists in a ‘‘closed’’ conformation in the
basal state, resulting from intramolecular interactions between
PRD1 and PRD2. Neuronal-stimulation-induced signaling and
the concomitant increase in CPEB3 levels could push these do-
mains to favor intermolecular, prion-based PRD1/PRD1- and
PRD2/PRD2-type interactions, which would be stabilized by in-
teractions with actin-binding proteins through the now-exposed
CPEB3 LMD domain. This interaction with the actin cytoskeleton
could in turn act to maintain CPEB3 in the ‘‘open’’ conformation,
locally concentrating the protein and leading to more efficient
prion seeding (Figure 7B).
Such a requirement for cytoskeletal interactions could consti-
tute a general property of functional prion formation, ensuring
that it only occurs in a tightly regulated context and safeguarding
the cell against toxic, out-of-control aggregation. In support of
that idea, interaction with actin has been reported for [PSI+]
and [LSB2+] in yeast (Bailleul-Winslett et al., 2000; Chernova
et al., 2011) and [Het-s] in Podospora anserina (Mathur et al.,
2010).
Conversely, escape from this regulatory control might pro-
mote the deleterious aggregation at the root of some prionll Reports 11, 1772–1785, June 23, 2015 ª2015 The Authors 1781
Figure 6. The Actin Cytoskeleton Is Essential for CPEB3 Aggregation, and Actin Is a Stimulation-Dependent CPEB3 Target
(A) Analysis of the effect of actin cytoskeleton depolymerization on CPEB3 foci formation. Freshly diluted cultures of cells carrying the indicated
constructs were simultaneously induced for construct expression and treated with 0.5 mM LatA or a DMSO control. The LatA concentration was the lowest
concentration that resulted in characteristic changes in yeast cell morphology based on a dose-response analysis (Figure S6). Imaging was performed at
48 hr ASI.
(B) Analysis of the effect of deletions in the components of the actin cytoskeleton on CPEB3 foci formation. The indicated deletion mutants as well as the isogenic
wild-type strains BY4741 and BY4742 were transformed with CPEB3-YFP or the CPEB3-1–217D-YFP. Imaging was at 48 hr ASI, with the exception of the sla2-D
strain, which was imaged at 60 hr ASI due to extremely slow growth. The wild-type image is for the BY4742 strain. Similar results were obtained with BY4741 (not
shown).
(C) RNA co-IP reveals CPEB3 (C3) interaction with actin mRNA in the mouse hippocampus. Total mouse hippocampal RNA was extracted, DNase I treated,
reverse transcribed, and subjected to PCR with primers specific for actin (top) or a GAPDH control (bottom). Actin mRNA, but not GAPDH mRNA, is detected in
the immunoprecipitates with CPEB3 antibody, but not in the bead-only control (A/G) or the controls lacking reverse transcriptase (-RT). The B lane is a control
lacking any cellular extract. Molecular weights are in base pairs.
(legend continued on next page)
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Figure 7. Model of the CPEB3 Prion Domain and Proposed Role of
the CPEB3/Actin Interaction at the Synapse
(A) N- and C-terminal deletion analysis of the CPEB3 prion domain reveals a
tripartite organization with three interacting modules: (1) domain 1–217 (PRD1)
is essential for prion seed formation and foci heritability and acts cooperatively
with PRD2 to impart prion properties to the CPEB3 protein, (2) domain 217–
284 (LMD) mediates an interaction with the actin cytoskeleton and could
regulate CPEB3 localization, and (3) domain 284–449 (PRD2) is essential for
CPEB3 foci formation.
(B) Proposed model for a CPEB3/actin positive feedback loop underlying
synaptic plasticity at stimulated synapses (see Discussion).diseases and amyloid-based neurological disorders. In fact,
cytoskeletal interactions are known for huntingtin (Hoffner
et al., 2002), alpha-synuclein (Alim et al., 2002), tau (Mandelkow
et al., 1996), and the precursor form of the prion protein, Pro-PrP
(Li et al., 2010).
Considering that actin is highly conserved between yeast and
mammals, it was not surprising that our finding of a CPEB3/actin
interaction in yeast was reproduced in the mouse brain and
specifically at synapses, reflecting an important physiological
function of CPEB3. Mapping of the CPEB3/actin interaction to
a region between PRD1 and PRD2 has some fascinating implica-
tions in the context of sustained synaptic plasticity and themain-
tenance of long-term memory. On the one hand, actin has been
extensively studied in that context (Dillon and Goda, 2005) and
has been hypothesized to be a candidate for the synaptic tag
(Ramachandran and Frey, 2009). Additionally, actin dynamics
are known to be modulated by the AMPA receptors (Dillon and(D) Luciferase assay showing that full-length CPEB3, but not CPEB3-1–217D, le
containing two CPE elements was fused to Renilla luciferase. Luciferase activity w
cells with or without the cotransfected actin 30 UTR. Black and gray bars refer to gl
is shown (Avg ± SE, n = 3). See Figure S6 for typical triple transfection efficienci
See also Figure S6.
CeGoda, 2005), themselves well-established CPEB3 targets
(Pavlopoulos et al., 2011). Our results demonstrate that CPEB3
colocalizes and interacts with actin and depends on the actin
cytoskeleton for its aggregation. On the other hand, previous
work in invertebrates had identified neuronal actin mRNA as a
target of Aplysia CPEB (Liu and Schwartz, 2003; Si et al.,
2003a), and we confirm in the mouse that b-actin mRNA is a
CPEB3 target and that stimulation-induced CPEB3 aggregation
leads to an increase of actin protein levels. Taken together,
these observations suggest the possibility of a positive feedback
loop at the basis of activity-induced synaptic plasticity, based
on interdependence of actin filament dynamics andCPEB3 prion
formation (Figure 7B). This loop would ultimately result in prion-
based stabilization of actin ultrastructure and establishment of
the long-lasting synaptic modifications that underlie long-term
memory persistence.
EXPERIMENTAL PROCEDURES
Yeast Strains and Plasmids
Unless otherwise mentioned, the strain used in this study was the [pin-][psi-]
derivative of the 74-D694 strain (a ade1-14 [UGA] his3-D200 ura3-52 leu2-3,
112 trp1-289 [UAG]; Chernoff et al., 1995). Centromeric plasmids (pRS300
and pRS400 series) controlled by theCUP1promoter were used as backbones
for all yeast constructs. See Table S1 for a complete list of plasmids used in
this study, and the Supplemental Experimental Procedures for other yeast
strains and details on plasmid construction.
Yeast Cultivation
Standard yeast media and cultivation procedures were used. All yeast
strains bearing plasmids for CPEB3 expression were grown in selective
synthetic complete medium at 30C. Unless otherwise stated, expression
of CUP1-driven proteins was induced by addition of 50 mM copper sulfate
to the growth medium, for the times indicated in the text or related figure
legends.
Methods
See the Supplemental Experimental Procedures for a detailed description of
biochemical and molecular methods used in this study.
Microscopy
Yeast cells were imaged on a confocal laser scanning microscope FV1000
(Olympus) with a 603/1.42-numerical-aperture oil-immersion objective. Im-
ages were analyzed with FV10-ASW software. Imaging was performed at
time points indicated in the figure legends. TEM was performed at the NYU
Langone Medical Imaging Core Facility.
Treatment of Animals
Mice were maintained under standard conditions consistent with NIH guide-
lines and approved by the Institutional Animal Care and Use Committee of
Columbia University.
Data Analysis
Number of repeats and (Avg) ± SE are stated in figure legends. Unless other-
wise mentioned, (Avg) ± SE was computed from at least 50 cells for each sam-
ple. Statistical significance wasmeasured by two-way ANOVA followed by the
Sidak multiple comparisons test.ads to a stimulation-induced increase in actin protein levels. The actin 30 UTR
as measured for EGFP alone, CPEB3, or CPEB3-1–217D (1–217D) transfected
ycine-stimulated and unstimulated conditions, respectively. Statistical analysis
es.
ll Reports 11, 1772–1785, June 23, 2015 ª2015 The Authors 1783
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
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